![Information](/productperformance-static/images/infow.png)
Device Survival Probability
MAXIMO_II_DR_SURV
1 yr | 2 yr | 3 yr | 4 yr | 5 yr | 6 yr | 7 yr | 8 yr | 9 yr | 10 yr | 11 yr | 12 yr | 13 yr | at 163.0 mo | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% | ![]() |
100.0 | 100.0 | 99.9 | 99.8 | 99.7 | 99.7 | 99.5 | 99.3 | 99.3 | 99.3 | 99.3 | 99.2 | 99.2 | 99.2 | |||||||
% | ![]() |
99.9 | 99.6 | 99.3 | 98.4 | 95.6 | 87.6 | 71.7 | 48.4 | 34.9 | 32.8 | 32.1 | 31.7 | 31.3 | 31.1 | |||||||
# | 17236 | 15934 | 14783 | 13616 | 12097 | 9583 | 5994 | 2813 | 1728 | 1473 | 1232 | 917 | 428 | 108 |
- Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
- Excluding Normal Battery Depletion – This is the malfunction free survival curve.
![Information](/productperformance-static/images/infow.png)
Product Characteristics
Generator Type | ICD |
---|---|
NBD Code | VVE-DDDR |
Max. Delivered Energy | 35 J |
Connector Style | DF4 DR Style |
---|---|
Serial Number Prefix | PUJ |
Mass | 73 g |
Volume | 41 cc |
Waveform | Biphasic |
X-Ray ID | PUG |
![Information](/productperformance-static/images/infow.png)
Estimated Longevity
Charging Frequency | 100% Pacing | 50% Pacing | 15% Pacing | 100% Sensing |
---|---|---|---|---|
Monthly | 3.6 | 4.1 | 4.5 | 4.7 |
Quarterly | 5.1 | 6.0 | 7.0 | 7.5 |
Semi-annual | 5.7 | 7.0 | 8.3 | 9.0 |
Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content
![Information](/productperformance-static/images/infow.png)
Distribution Data
US Market Release | 2012-01-09 |
---|---|
CE Approval Date | 2010-07-22 |
Registered USA Implants | 6 |
Estimated Active USA Implants | 0 |
Normal Battery Depletions | 2 |
US Market Release | 2012-01-09 |
---|---|
CE Approval Date | 2010-07-22 |
Estimated WW Distribution | 6106 |
Normal Battery Depletions | 2 |
![Information](/productperformance-static/images/infow.png)
EOS Indication
The Prolonged Service Period (PSP) is the time between the RRT and EOS. The PSP is defined as 3 months assuming the following conditions: 100% DDD pacing at 60 min-1, 2.5 V atrial and RV pacing amplitude; 0.4 ms pulse width; 600 Ω pacing load; and 6 full-energy charges. The EOS may be indicated before the end of 3 months if the device exceeds these conditions.
Data as of December 1, 2023